Pyrazolidines in the treatment of gout.
D000208:Acute Disease; D000493:Allopurinol / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use*; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D014528:Uricosuric Agents / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D014528:Uricosuric Agents; D000493:Allopurinol; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D013442:Sulfinpyrazone